<SEC-DOCUMENT>0000950170-24-099617.txt : 20240821
<SEC-HEADER>0000950170-24-099617.hdr.sgml : 20240821
<ACCEPTANCE-DATETIME>20240821190639
ACCESSION NUMBER:		0000950170-24-099617
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20240819
FILED AS OF DATE:		20240821
DATE AS OF CHANGE:		20240821

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Comcowich Kevin
		CENTRAL INDEX KEY:			0001688770
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37383
		FILM NUMBER:		241229771

	MAIL ADDRESS:	
		STREET 1:		C/O ARCADIA BIOSCIENCES, INC.
		STREET 2:		202 COUSTEAU PLACE, SUITE 105
		CITY:			DAVIS
		STATE:			CA
		ZIP:			95618

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Arcadia Biosciences, Inc.
		CENTRAL INDEX KEY:			0001469443
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE PRODUCTION - CROPS [0100]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				810571538
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		202 COUSTEAU PLACE
		STREET 2:		SUITE 105
		CITY:			DAVIS
		STATE:			X1
		ZIP:			95618
		BUSINESS PHONE:		530-756-7077

	MAIL ADDRESS:	
		STREET 1:		202 COUSTEAU PLACE
		STREET 2:		SUITE 105
		CITY:			DAVIS
		STATE:			CA
		ZIP:			95618
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0508</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2024-08-19</periodOfReport>

    <issuer>
        <issuerCik>0001469443</issuerCik>
        <issuerName>Arcadia Biosciences, Inc.</issuerName>
        <issuerTradingSymbol>RKDA</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001688770</rptOwnerCik>
            <rptOwnerName>Comcowich Kevin</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O ARCADIA BIOSCIENCES, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>5950 SHERRY LANE, SUITE 215</rptOwnerStreet2>
            <rptOwnerCity>DALLAS</rptOwnerCity>
            <rptOwnerState>TX</rptOwnerState>
            <rptOwnerZipCode>75225</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>true</isDirector>
            <isOfficer>false</isOfficer>
            <isTenPercentOwner>false</isTenPercentOwner>
            <isOther>false</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>false</aff10b5One>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Option (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>2.71</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2024-08-19</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>false</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>25455</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0.00</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2034-08-19</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>25455</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>31042</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>Kevin Comcowich, by Attorney-in-fact, Solaeta Chan</signatureName>
        <signatureDate>2024-08-21</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
